NPI: 1194052761 · CHARLOTTE, NC 28211 · Pediatrics Physician · NPI assigned 11/03/2009
Authorized official RISSMILLER, SCOTT controls 20+ related entities in our dataset. Read more
| Authorized Official | RISSMILLER, SCOTT (ENTERPRISE EVP) |
| Parent Organization | CHARLOTTE PEDIATRIC CLINIC |
| NPI Enumeration Date | 11/03/2009 |
Other providers sharing the same authorized official: RISSMILLER, SCOTT
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 2,365 | $63K |
| 2019 | 2,931 | $94K |
| 2020 | 2,547 | $78K |
| 2021 | 17,257 | $254K |
| 2022 | 28,835 | $320K |
| 2023 | 36,148 | $410K |
| 2024 | 45,706 | $467K |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 99213 | Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 9,120 | 7,577 | $523K |
| 99199 | Unlisted special service, procedure or report | 95,851 | 66,242 | $480K |
| 99214 | Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 2,649 | 2,200 | $227K |
| 90460 | Immunization administration through 18 years of age via any route, first or only component | 2,653 | 2,330 | $129K |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | 1,478 | 1,210 | $117K |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | 3,957 | 3,118 | $65K |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | 581 | 494 | $52K |
| 90472 | Immunization administration, each additional vaccine (list separately) | 995 | 754 | $28K |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | 162 | 150 | $14K |
| 96110 | Developmental screening, with scoring and documentation, per standardized instrument | 4,311 | 3,640 | $14K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | 190 | 166 | $7K |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | 102 | 89 | $6K |
| 0001A | 150 | 80 | $5K | |
| 96127 | 1,303 | 1,128 | $5K | |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | 59 | 42 | $4K |
| 0002A | 159 | 71 | $4K | |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 63 | 32 | $2K |
| 90686 | 1,848 | 1,572 | $881.04 | |
| 0071A | 14 | 12 | $773.14 | |
| 0072A | 21 | 12 | $455.00 | |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | 17 | 14 | $393.12 |
| 96161 | 169 | 134 | $350.83 | |
| 90677 | 391 | 373 | $295.84 | |
| G2211 | Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's single, serious condition or a complex condition. (add-on code, list separately in addition to office/outpatient evaluation and management visit, new or established) | 87 | 84 | $289.64 |
| 99401 | 18 | 15 | $268.10 | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | 19 | 13 | $207.76 |
| 92551 | 110 | 90 | $146.19 | |
| 87081 | 20 | 13 | $104.58 | |
| 90656 | 380 | 356 | $64.41 | |
| 99173 | 180 | 155 | $23.54 | |
| 99177 | 70 | 61 | $7.75 | |
| 3074F | 407 | 362 | $0.00 | |
| 90723 | 243 | 227 | $0.00 | |
| 3008F | 459 | 444 | $0.00 | |
| 91307 | 76 | 40 | $0.00 | |
| 90680 | 180 | 174 | $0.00 | |
| 90647 | 128 | 115 | $0.00 | |
| 1160F | 2,511 | 2,336 | $0.00 | |
| 1159F | 4,026 | 3,535 | $0.00 | |
| 3078F | 388 | 350 | $0.00 | |
| 90670 | 231 | 150 | $0.00 | |
| 90633 | 13 | 12 | $0.00 |